Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus
Oral Lichen Planus
About this trial
This is an interventional treatment trial for Oral Lichen Planus
Eligibility Criteria
Inclusion Criteria:
- Patients presented with painful oral lichen planus lesions
- Free of any visible oral lesions other than oral lichen planus
- Free of any systemic diseases
Exclusion Criteria:
- Topical treatment or systemic therapy of OLP for one month before starting the study
- Pregnant or breast feeding women
- Smokers
- Use of corticosteroids or other immunosuppressive drugs
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Experimental
control subjects
OLP and corticosteroid
OLP and corticosteroid and green tea
10 systemically healthy control subjects taking no medication.
15 Patients who were previously diagnosed with oral lichen planus presented in acute exacerbation were treated with topical corticosteroids; Triamcinolone acetonide (Kenalog in orabase: Bristol-Myers, Squibb, Spain) applied topically 4 times a day i.e. following each meal and at bed time for one month.
15 Patients who were previously diagnosed with oral lichen planus presented in acute exacerbation were treated with both topical corticosteroids; Triamcinolone acetonide (Kenalog in orabase: Bristol-Myers, Squibb, Spain) applied topically 4 times a day i.e. following each meal and at bed time for one month in addition to green tea tablets 200 mg (Green tea extract 5:1, El Obour For Modern Pharmaceutical Industries) as one tablet a day also for one month.